AstraZeneca Shares Surge 14% as Investment Pause Spurs Fresh Valuation Debate

If you own AstraZeneca stock or are thinking about jumping in, this is one of those moments that begs your attention. With ...

A Look Into AstraZeneca Inc's Price Over Earnings

Compared to the aggregate P/E ratio of the 82.48 in the Pharmaceuticals industry, AstraZeneca Inc. has a lower P/E ratio of ...

Trump announces drug pricing deal with AstraZeneca

President Trump on Friday announced another major pharmaceutical company had agreed to his “most favored nation” (MFN) policy ...

AstraZeneca (LSE:AZN): Exploring Valuation as Shares Move Steadily Higher

AstraZeneca (LSE:AZN) shares have moved slightly in recent sessions, which prompts investors to consider how recent trading ...

Next medicine deal after Pfizer? Analysts, shares point to AstraZeneca, Eli Lilly

Wall Street is looking to U.S. drugmaker Eli Lilly and Anglo-Swedish rival AstraZeneca as the potential next in line after ...
Fintel on MSN

Shore Capital Reiterates AstraZeneca (AZNCF) Buy Recommendation

Fintel reports that on October 7, 2025, Shore Capital reiterated coverage of AstraZeneca (OTCPK:AZNCF) with a Buy recommendation. Analyst Price Forecast Suggests 12.41% Upside As of September 30, 2025 ...